OR6A2
gene geneOn this page
Also known as OR11-55
Summary
OR6A2 (olfactory receptor family 6 subfamily A member 2, HGNC:15301) is a protein-coding gene on chromosome 11p15.4, encoding Olfactory receptor 6A2 (O95222). Odorant receptor.
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome.
Source: NCBI Gene 8590 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 67 total
- MANE Select transcript:
NM_003696
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:15301 |
| Approved symbol | OR6A2 |
| Name | olfactory receptor family 6 subfamily A member 2 |
| Location | 11p15.4 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | OR11-55 |
| Ensembl gene | ENSG00000184933 |
| Ensembl biotype | protein_coding |
| OMIM | 608495 |
| Entrez | 8590 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000641196
RefSeq mRNA: 1 — MANE Select: NM_003696
NM_003696
CCDS: CCDS7772
Canonical transcript exons
ENST00000641196 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003812698 | 6791736 | 6795884 |
| ENSE00003813717 | 6799544 | 6799689 |
Expression profiles
Bgee: expression breadth tissue_specific, 3 present calls, max score 83.10.
Top tissues by expression
121 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.10 | gold quality |
| bone marrow cell | CL:0002092 | 59.51 | silver quality |
| sural nerve | UBERON:0015488 | 47.26 | gold quality |
| bone marrow | UBERON:0002371 | 44.98 | silver quality |
| calcaneal tendon | UBERON:0003701 | 41.46 | gold quality |
| colonic epithelium | UBERON:0000397 | 41.16 | gold quality |
| primary visual cortex | UBERON:0002436 | 39.15 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 38.30 | gold quality |
| tonsil | UBERON:0002372 | 38.19 | gold quality |
| ganglionic eminence | UBERON:0004023 | 37.14 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 34.74 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 33.71 | gold quality |
| lymph node | UBERON:0000029 | 33.70 | gold quality |
| uterine cervix | UBERON:0000002 | 33.23 | gold quality |
| monocyte | CL:0000576 | 33.10 | gold quality |
| leukocyte | CL:0000738 | 32.61 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| muscle tissue | UBERON:0002385 | 32.06 | gold quality |
| adrenal tissue | UBERON:0018303 | 31.99 | gold quality |
| urinary bladder | UBERON:0001255 | 31.84 | gold quality |
| endometrium | UBERON:0001295 | 31.72 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 31.24 | gold quality |
| liver | UBERON:0002107 | 30.95 | gold quality |
| endocervix | UBERON:0000458 | 30.81 | gold quality |
| putamen | UBERON:0001874 | 30.66 | gold quality |
| ectocervix | UBERON:0012249 | 30.24 | gold quality |
| body of uterus | UBERON:0009853 | 30.19 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.25 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): LHX2
miRNA regulators (miRDB)
11 targeting OR6A2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-7110-3P | 100.00 | 73.18 | 2486 |
| HSA-MIR-6845-3P | 99.94 | 66.88 | 1439 |
| HSA-MIR-376A-3P | 99.06 | 69.17 | 1128 |
| HSA-MIR-376B-3P | 99.06 | 69.17 | 1128 |
| HSA-MIR-361-5P | 98.95 | 70.16 | 1340 |
| HSA-MIR-374A-3P | 98.87 | 67.82 | 1531 |
| HSA-MIR-640 | 98.44 | 66.93 | 644 |
| HSA-MIR-4529-3P | 96.40 | 66.46 | 582 |
| HSA-MIR-5704 | 94.82 | 67.46 | 448 |
| HSA-MIR-6503-3P | 93.87 | 66.39 | 348 |
| HSA-MIR-1295A | 85.69 | 62.42 | 75 |
Literature-anchored findings (GeneRIF, showing 3)
- I7 olfactory receptor (PMID:20608641)
- Olfactory receptor 2 in vascular macrophages drives atherosclerosis by NLRP3-dependent IL-1 production. (PMID:35025664)
- Odorant receptors in macrophages: potential targets for atherosclerosis. (PMID:35283015)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Or6a2 | ENSMUSG00000070417 |
| rattus_norvegicus | Or6a2 | ENSRNOG00000085613 |
Paralogs (92): OR2B6 (ENSG00000124657), OR13C9 (ENSG00000136839), OR13C4 (ENSG00000148136), OR2M5 (ENSG00000162727), OR10A5 (ENSG00000166363), OR2D2 (ENSG00000166368), OR2B2 (ENSG00000168131), OR2C1 (ENSG00000168158), OR13J1 (ENSG00000168828), OR10G3 (ENSG00000169208), OR10A3 (ENSG00000170683), OR10A4 (ENSG00000170782), OR10A2 (ENSG00000170790), OR13H1 (ENSG00000171054), OR2K2 (ENSG00000171133), OR2M4 (ENSG00000171180), OR10H2 (ENSG00000171942), OR10H5 (ENSG00000172519), OR10AD1 (ENSG00000172640), OR2Y1 (ENSG00000174339), OR10AG1 (ENSG00000174970), OR2T1 (ENSG00000175143), OR10P1 (ENSG00000175398), OR2T35 (ENSG00000177151), OR2M7 (ENSG00000177186), OR2T12 (ENSG00000177201), OR2T33 (ENSG00000177212), OR2AJ1 (ENSG00000177275), OR2T8 (ENSG00000177462), OR2G3 (ENSG00000177476), OR2G2 (ENSG00000177489), OR2B11 (ENSG00000177535), OR2D3 (ENSG00000178358), OR13D1 (ENSG00000179055), OR10A7 (ENSG00000179919), OR2Z1 (ENSG00000181733), OR2V2 (ENSG00000182613), OR10G7 (ENSG00000182634), OR2T29 (ENSG00000182783), OR2T34 (ENSG00000183310)
Protein
Protein identifiers
Olfactory receptor 6A2 — O95222 (reviewed: O95222)
Alternative names: Olfactory receptor 11-55, Olfactory receptor 6A1, Olfactory receptor OR11-83, hP2 olfactory receptor
All UniProt accessions (2): O95222, A0A126GW91
UniProt curated annotations — full annotation on UniProt →
Function. Odorant receptor.
Subcellular location. Cell membrane.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (1): NP_003687* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000725 | Olfact_rcpt | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
| IPR050939 | Olfactory_GPCR1 | Family |
Pfam: PF13853
UniProt features (28 total): topological domain 8, sequence conflict 8, transmembrane region 7, glycosylation site 2, chain 1, disulfide bond 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O95222-F1 | 83.59 | 0.47 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 102–194
Glycosylation sites (2): 5, 191
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9752946 | Expression and translocation of olfactory receptors |
MSigDB gene sets: 51 (showing top):
GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_MCMV_INFECTION_DN, GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, KEGG_OLFACTORY_TRANSDUCTION, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, GOMF_OLFACTORY_RECEPTOR_ACTIVITY, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, YOSHIMURA_MAPK8_TARGETS_UP, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_SENSORY_PERCEPTION_OF_SMELL, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, PEDRIOLI_MIR31_TARGETS_DN, PRC2_SUZ12_UP.V1_DN, IL2_UP.V1_UP
GO Biological Process (4): signal transduction (GO:0007165), sensory perception of smell (GO:0007608), detection of chemical stimulus involved in sensory perception of smell (GO:0050911), G protein-coupled receptor signaling pathway (GO:0007186)
GO Molecular Function (2): G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Olfactory Signaling Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transmembrane signaling receptor activity | 2 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| sensory perception of chemical stimulus | 1 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
352 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OR6A2 | BRI3 | O95415 | 766 |
| OR6A2 | TAS2R1 | Q9NYW7 | 471 |
| OR6A2 | GSG1 | Q2KHT4 | 369 |
| OR6A2 | SCNN1B | P51168 | 336 |
| OR6A2 | MTRNR2L7 | P0CJ74 | 328 |
| OR6A2 | TMEM39B | Q9GZU3 | 310 |
| OR6A2 | TAS1R2 | Q8TE23 | 304 |
| OR6A2 | CASKIN2 | Q8WXE0 | 269 |
| OR6A2 | RIC8B | Q9NVN3 | 259 |
| OR6A2 | SLF2 | Q8IX21 | 246 |
| OR6A2 | TAS2R19 | P59542 | 228 |
| OR6A2 | SH3BGR | P55822 | 223 |
| OR6A2 | CNGA4 | Q8IV77 | 222 |
| OR6A2 | TAS2R38 | P59533 | 219 |
| OR6A2 | RHEBL1 | Q8TAI7 | 217 |
| OR6A2 | CNGA2 | Q16280 | 217 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| OR6A2 | KIAA1549 | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (1): KIAA1549 (Affinity Capture-MS)
ESM2 similar proteins: A0A2R8YED5, A6NM03, O14581, O60412, O95006, O95047, O95222, O95371, P23270, P34982, P34984, P58170, Q15622, Q5TZ20, Q60883, Q60889, Q60891, Q6IF42, Q6IFH4, Q7Z3T1, Q8N349, Q8N628, Q8NG92, Q8NG95, Q8NG98, Q8NGA1, Q8NGE9, Q8NGQ2, Q8NGQ5, Q8NGR1, Q8NGR9, Q8NGS0, Q8NGS2, Q8NGS3, Q8NGV0, Q8NGX1, Q8NH03, Q8NH80, Q8NHA4, Q8NHA6
Diamond homologs: A6NCV1, A6NDL8, A6NF89, A6NIJ9, A6NJZ3, A6NL08, A6NL26, A6NM76, O14581, O76000, O76100, O95007, O95222, P0C617, P0C626, P0C7N5, P23266, P23267, P23269, P23270, P23272, P30955, P34985, P34986, P47890, P58173, P59922, P70526, Q15622, Q5TZ20, Q60882, Q60886, Q6IEU7, Q6UXT6, Q8N0Y5, Q8N127, Q8N146, Q8N148, Q8N162, Q8N628
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
67 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 63 |
| Likely benign | 3 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
172 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:6795677:CTCA:C | donor_gain | 0.9700 |
| 11:6795680:A:AC | donor_gain | 0.9700 |
| 11:6795681:C:CC | donor_gain | 0.9700 |
| 11:6795681:CT:C | donor_gain | 0.9700 |
| 11:6795676:A:AC | donor_gain | 0.9600 |
| 11:6795677:C:CC | donor_gain | 0.9600 |
| 11:6795684:T:A | donor_gain | 0.9600 |
| 11:6795218:TTG:T | donor_gain | 0.9500 |
| 11:6795680:ACTCT:A | donor_gain | 0.9500 |
| 11:6795681:CTCTC:C | donor_gain | 0.9500 |
| 11:6795681:CTCT:C | donor_gain | 0.9200 |
| 11:6795725:A:AC | donor_gain | 0.9100 |
| 11:6795726:C:CC | donor_gain | 0.9100 |
| 11:6795726:CTG:C | donor_gain | 0.8600 |
| 11:6795677:CT:C | donor_gain | 0.8400 |
| 11:6795726:CTGCT:C | donor_gain | 0.7900 |
| 11:6795407:C:A | donor_gain | 0.7600 |
| 11:6795705:C:CA | donor_gain | 0.7600 |
| 11:6795721:T:TA | donor_gain | 0.7400 |
| 11:6795628:TAGTA:T | donor_loss | 0.7000 |
| 11:6795629:AGTAC:A | donor_loss | 0.7000 |
| 11:6795630:GTACC:G | donor_loss | 0.7000 |
| 11:6795631:TA:T | donor_loss | 0.7000 |
| 11:6795632:ACCTG:A | donor_loss | 0.7000 |
| 11:6795633:C:A | donor_loss | 0.7000 |
| 11:6795634:C:A | donor_loss | 0.7000 |
| 11:6795678:T:C | donor_gain | 0.6900 |
| 11:6794930:CTGG:C | acceptor_gain | 0.6700 |
| 11:6795635:T:C | donor_loss | 0.6700 |
| 11:6794937:C:CA | acceptor_gain | 0.6300 |
AlphaMissense
2133 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:6795670:A:C | F13L | 0.978 |
| 11:6795670:A:T | F13L | 0.978 |
| 11:6795672:A:G | F13L | 0.978 |
| 11:6795143:A:G | L189S | 0.965 |
| 11:6795671:A:C | F13C | 0.959 |
| 11:6795163:A:C | F182L | 0.958 |
| 11:6795163:A:T | F182L | 0.958 |
| 11:6795165:A:G | F182L | 0.958 |
| 11:6795158:C:G | C184S | 0.955 |
| 11:6795159:A:T | C184S | 0.955 |
| 11:6795160:G:C | F183L | 0.952 |
| 11:6795160:G:T | F183L | 0.952 |
| 11:6795162:A:G | F183L | 0.952 |
| 11:6795665:A:G | L15S | 0.947 |
| 11:6795158:C:T | C184Y | 0.943 |
| 11:6795140:A:G | L190P | 0.940 |
| 11:6795143:A:C | L189W | 0.938 |
| 11:6795671:A:G | F13S | 0.936 |
| 11:6794929:A:C | S260R | 0.934 |
| 11:6794929:A:T | S260R | 0.934 |
| 11:6794931:T:G | S260R | 0.934 |
| 11:6795159:A:G | C184R | 0.934 |
| 11:6795382:G:C | F109L | 0.931 |
| 11:6795382:G:T | F109L | 0.931 |
| 11:6795384:A:G | F109L | 0.931 |
| 11:6794941:G:C | F256L | 0.930 |
| 11:6794941:G:T | F256L | 0.930 |
| 11:6794943:A:G | F256L | 0.930 |
| 11:6795158:C:A | C184F | 0.929 |
| 11:6795134:A:G | L192P | 0.924 |
dbSNP variants (sampled 300 via entrez): RS1000997044 (11:6800985 C>T), RS1001182659 (11:6799098 A>C), RS1001479897 (11:6797670 C>T), RS1001844619 (11:6799128 G>A,C), RS1002059624 (11:6794996 C>T), RS1002211351 (11:6800681 T>A,C), RS1002697123 (11:6792287 C>T), RS1002733182 (11:6792558 A>G), RS1002846447 (11:6800505 T>C), RS1002987654 (11:6794491 T>C,G), RS1003261240 (11:6792391 AACATTGGAAACC>A), RS1003443788 (11:6800290 G>A,C), RS1004227606 (11:6791905 A>G), RS1005124022 (11:6797804 T>C), RS1005234783 (11:6793087 G>A)
Disease associations
OMIM: gene MIM:608495 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010725_20 | Malaria | 4.000000e-69 |
| GCST010725_33 | Malaria | 2.000000e-67 |
| GCST010725_51 | Malaria | 1.000000e-55 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
8 total (human), top 8 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| CGP 52608 | increases reaction, affects binding | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Lead | increases expression | 1 |
| Methotrexate | increases expression | 1 |
| Rotenone | increases expression | 1 |
| Valproic Acid | decreases methylation | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Asbestos, Crocidolite | affects expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.